Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

European shares end fifth week higher on rate-cut optimism

Published 12/15/2023, 03:22 AM
Updated 12/15/2023, 12:12 PM
© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, December 6, 2023. REUTERS/Staff/File Photo

By Ankika Biswas and Bansari Mayur Kamdar

(Reuters) -European shares inched up on the final day of a week marked by major central bank policy decisions, in which the U.S. Federal Reserve set the tone for market expectations about interest rate cuts being on the horizon.

The pan-European STOXX 600 edged 0.1% higher on Friday, posting its fifth straight weekly advance and recording its longest weekly winning streak since April.

The German benchmark DAX was flat, while France's CAC-40 climbed 0.3% after both hit record highs on Thursday.

For the week, rate-sensitive real estate stocks were the top gainers, while the telecommunication sector took the worst hit.

On the policy front, the Fed stood out, signalling lower borrowing costs in 2024, while the European Central Bank held rates steady, pushing back against rate-cut bets on Thursday.

"Our economists see... the hawkish tilt of (Thursday's ECB meeting) as reducing the risk of the ECB cutting as soon as March, but retain their view of rate cuts starting in April with 150 bps of cuts by the end of next year," Deutsche Bank said in a note.

Barclays forecast a 25-basis-point ECB rate cut in April and consecutive cuts in each policy meeting until January 2025.

Meanwhile, ECB policymaker Francois Villeroy de Galhau said although the ECB's next move should be lowering rates, it should first "enjoy the view" for a while.

Economic concerns were underscored by weak data showing Germany's economic downturn worsened this month, pointing to a recession in Europe's biggest economy at the year-end, and French business activity declined faster than expected in December.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Weakness in the healthcare sector weighed for the day, with UK-based GSK slipping 2.9% after EU regulator pulled the plug on company's blood cancer drug.

Swedish technology firm Sectra jumped 8.3% to the top of STOXX 600 following second-quarter results.

Stockholm-listed receipts of Millicom gained 2.7% after the telecom group raised its target and launched a share buyback program.

EQT (ST:EQTAB) rose 4.3% after J.P. Morgan upgraded the Swedish private equity firm to "neutral" from "underweight".

Symrise lost 7.6% after the German flavour and fragrance maker cut its full-year EBITDA margin guidance.

Campari (LON:0ROY) shed 2.9% after the Italian spirits group announced its biggest-ever acquisition to buy French cognac house Courvoisier for $1.2 billion.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.